Skip to content

Prospective cohort study of deep brain stimulation for dystonia

Prospective cohort study of deep brain stimulation for dystonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043134
Enrollment
Unknown
Registered
2021-02-05
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonia

Interventions

dystonia patients treated with DBS:Deep brain stimulation

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosis with dystonia; 2) Age at recruition ranges from 7 to 75 years old; 3) Meet one of the following conditions: a) Oral drugs can not effectively improve the motor symptoms, activities of daily living and severe pain of simple (idiopathic or hereditary) systemic dystonia, simple (idiopathic or hereditary) segmental dystonia, simple (idiopathic or hereditary) focal dystonia. b) Neurodegenerative diseases characterized by dystonia (systemic, segmental and focal) and with or without other symptoms of dyskinesia. c) The moderate and severe acquired dystonia with poor drug treatment effect mainly refers to delayed systemic, segmental and focal dystonia. 4) Those who can perform deep brain stimulation and cooperate with follow-up; 5) Willing to participate in clinical trials, and able to sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with severe (refractory) depression, anxiety, schizophrenia and other mental diseases, and the drug can not effectively control the mental symptoms; 2) There is obvious cognitive impairment, and this cognitive impairment is enough to affect the ability of daily life of patients; 3) There are obvious medical coexisting diseases affecting the operation or survival of patients; 4) Dopa responsive dystonia, paroxysmal dystonia and psychogenic dystonia; 5) Cardiac pacemaker, defibrillator, cochlear implant and other nerve stimulator have been implanted or need to be implanted; 6) Long term use of immunosuppressants or hormone therapy is required; 7) Having other types of diseases that need repeated MRI examination; 8) Unwilling or unable to cooperate with postoperative follow-up.

Design outcomes

Primary

MeasureTime frame
The severity of the disease;Laboratory inspection;Demography;Medical history;non-motor symptoms;imaging inspection;

Countries

China

Contacts

Public ContactHuifang Shang

Department of Neurology, West China Hospital of Sichaun University

hfshang2002@163.com+86 18980602127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026